C-I5HIPelage Pharmaceuticals
stem cell activation, topical small molecule, metabolic switch
modulatingsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-I5HI
C-I5HIC-I5HIstem cell activation, topical small molecule, metabolic switch
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Pelage states that hair loss should be treated by directly targeting hair follicle stem cells through their intrinsic metabolic properties, using a first-in-class, non-invasive topical small-molecule platform grounded in stem cell biology. The company presents current treatments as inadequate because they often target external factors, have limited efficacy or unclear mechanisms, may not be FDA-approved, and can be invasive or require oral dosing. Pelage believes its approach can stimulate robust hair growth and be suitable for all genders, skin types, and hair types.
SourcePelage Pharmaceuticals appears to frame hair loss as a regenerative-medicine problem: hair follicles are not necessarily gone, but can become dormant, and changing hair follicle stem-cell metabolism may reactivate growth. The company’s stated belief is that targeting the metabolic state of these stem cells could restore hair growth more directly than conventional approaches that mainly slow loss or preserve existing follicles.
SourcePelage’s stated position was that common hair loss is not simply irreversible follicle loss, but a problem of hair follicle stem cells becoming dormant, and that hair can potentially be regenerated by reactivating those preserved stem cells through metabolic intervention rather than only slowing further loss. The company framed its approach as regenerative and mechanism-driven, aimed at restoring natural hair growth by waking up inactive follicles.
SourcePelage Pharmaceuticals presented itself as a regenerative medicine company built on the belief that hair loss can be treated by reactivating dormant hair follicle stem cells rather than merely slowing loss or masking it. Its stated position was that follicle biology remains recoverable, and that targeted metabolic control of these stem cells could restore normal hair growth.
SourcePelage Pharma states that hair loss should be treated through a scientifically based, non-invasive topical drug that directly targets the intrinsic metabolism of hair follicle stem cells rather than external contributors to hair loss. The company presents this approach as broadly applicable across multiple forms of alopecia in both men and women, with the potential to stimulate robust hair growth without invasive procedures or unwanted oral-systemic exposure.
SourcePelage states that hair loss should be treated by directly targeting hair follicle stem cells through their intrinsic metabolism rather than relying on existing therapies that focus on external factors, have limited efficacy, unclear mechanisms, invasive procedures, or oral systemic exposure. The company presents its approach as a novel, non-invasive, topical small-molecule platform based on a metabolic switch in hair follicle stem cells, with the potential to stimulate robust hair growth across genders, skin types, and hair types.
Source